Nano Biotechnology Market

Nano Biotechnology Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Increasing demand of new therapies for various tissues of lungs and cardiac as well as rising organizations investment in research and development for new drugs are some important factors driving the growth of Nano biotechnology market.

Nano biotechnology is application of nanotechnology which is applied in biological field. The concept nanotechnology means a designed, development and applications of material which functional make up is on a nanometer scale. Technically nanotechnology is developing material or other structured material which is size from 1 to 100 nanometers. And biotechnology means the study of biological subjects including microorganism. Nano biotechnology is intersection of biology and nanotechnology. Nano biotechnology is a study of biological and biochemical applications. Nano biotechnology is used to study the nature of fabricating new Nano devices and elements which exists in living organisms. The use of Nano biotechnology in commercial applications in biomedical field is direction towards development of new techniques in biosciences and drug delivery systems.

The global nano biotechnology is segmented on the basis of applications, therapeutics and by regional basis. Based on application the global Nano biotechnology is segmented as medical research, medical devices, pharmaceuticals and others. On the basis of therapeutics the global Nano biotechnology market is divided as orthopedic therapies, dental therapies, cardiac therapies and others.

The regions covered in global Nano biotechnology report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Nano biotechnology sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Nano Biotechnology Companies:

Global Nano biotechnology reports cover prominent players like,

• Dabur Pharma
• cellix
• InanoBio
• Marina Biotech
• dermaCM
• Ablynx
• Xantac Bioanalytics
• AC Serndip
• WaveSense
• Nanobiotech Pharma
• Celgene
• Thermo Fisher Scientific
• merck KGaA
• Bionano Genomics
• Others

New Nano drug candidate kills aggressive breast cancer cells

News: July 20, 2020- The researchers at the University of Arkansas have developed a new Nano drug candidate that kills triple-negative breast cancer cells. Triple-negative breast cancer is one of the most aggressive and fatal types of breast cancer. The research will help clinicians target breast cancer cells directly while avoiding the adverse and toxic side effects of chemotherapy. The American Cancer Society estimated 268,600 new cases of invasive breast cancer in 2019 and 41,760 deaths. Researchers in Beyzavi’s laboratory focus on developing new targeted photodynamic therapy drugs, as alternative to chemotherapy and significantly fewer side effects.

Nano Biotechnology Dynamics –

The key factor for growth of global Nano biotechnology is increasing advancements in medical science to improve healthcare practices around the world for better drug delivery system which drives the growth of Nano biotechnology market. The product of Nano biotechnology is under trial but scientist have confident that this trail will give positive result to increase the prevention process, diagnosis and treatment of various diseases. Nano biotechnology is also used in areas like electronics, biomaterial and energy production. The public and private companies are also showing keen interest in Nano biotechnology which gives commercial platform for the product of Nano biotechnology.

More detailed research is required to introduce diverse components of Nano biotechnology in medical applications which restrain the growth of global Nano biotechnology market. The effect of toxicity of Nano material on environment and economy affect the growth of Nano biotechnology market. However the increase in government initiative for research and development in Nano biotechnology will increase opportunities of Nano biotechnology market in future.

The National Nanotechnology Initiatives (NNI) funded approximately USD 170 billion in 2018. Currently there are 60 countries which is member of National Nanotechnology Initiative and conducted program on National Nanotechnology. According to National institute of standard there are 1700 nanotechnology companies worldwide.

Nano Biotechnology Regional Analysis –

North America is dominating the growth nano biotechnology due to increase in investment in research and development projects and implementing flexible policies. The National Nanotechnology Initiatives which was established in 2001 which develop nanotechnology within United States. There is 3729 patent registered in USA on Nanotechnology in 2018. European Union is expected to emerge the growth of share in global Nano biotechnology market. To increase in research and development spending and investment in public and private sectors of Nano biotechnology. The European Union has published the publications on Nano biotechnology.

Asia Pacific is also emerging in the field of nano biotechnology. India has introduced Nano biotechnology based chemotherapy. The Nano biotechnology have introduced polymer free drug for treatment of cardiac disease. The drug name is Sirolimous which shows extreme excellent result which reduces the blockages of in the arteries. China has duplicated research paper and publication about 3592 and 30.479 respectively. The patent on Nano biotechnology of china is 5030 in 2019.

Key Benefits for Nano biotechnology reports –

Global Nano biotechnology report covers in depth historical and forecast analysis.

Global Nano biotechnology Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global Nano biotechnology report helps to identify opportunities in market place.

Global Nano biotechnology report covers extensive analysis of emerging trends and competitive landscape.

Nano Biotechnology Segmentation –

• by Application: Medical Devices, Pharmaceuticals, Medical research, Others
• by Therapeutics: Cardiac Therapies, Orthopedic Therapies, Dental therapies, Others

 

Regional & Country Analysis

North America

• u.s
• Canada

Europe

• Germany
• France
• K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA